| Patients sent to Accra for Bone Scintigraphy (N = 36) | |
| mean age (age range) | 63.9 (42 - 77) |
| mean PSA (PSA range) | 45.02 (5.2 - 287.4) |
| ISUP grade group | n (%) of patients |
| 1 | 11 (30.6) |
| 2 | 9 (25.0) |
| 3 | 7 (19.4) |
| 4 | 5 (13.9) |
| 5 | 4 (11.1) |
| Patients who performed the Bone Scintigraphy (n = 28) | |
| mean age (age range) | 63.04 (48 - 77) |
| mean PSA (PSA range) | 50.22 (5.2 - 287.4) |
| n (%) with PSA ˂ 30 | 16 (57.1) |
| n (%) with PSA ≥ 30 | 12 (42.9) |
| n (%) with PSA ˂ 100 | 23 (82.1) |
| n (%) with PSA ≥ 100 | 5 (17.9) |
| ISUP grade group | n (%) of patients |
| 1 | 11 (39.3) |
| 2 | 4 (14.3) |
| 3 | 6 (21.4) |
| 4 | 3 (10.7) |
| 5 | 4 (14.3) |
| n (%) of bone metastatic patients | 6 (21.4) |
| n (%) of bone metastasis-free patients | 22 (78.6) |
| number of bone metastatic sites | n (%) patients |
| <3 | 3 (10.71) |
| ≥3 | 3 (10.71) |